i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

Developing a strategy to specifically kill cancer cells without inducing obvious damage to normal cells may be of great clinical significance for cancer treatment. In the present study, we developed a new precise personalized strategy named "i-CRISPR" for cancer treatment through adding DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Junfeng, Chen, Yuanyuan, Zhang, Li, Jin, Qishu, Wang, Liujun, Xu, Sha, Chen, Kexin, Li, Li, Zeng, Tao, Fan, Xingfei, Liu, Tingting, Li, Jiaxi, Wang, Jinjiang, Han, Chaofeng, Gao, Fu, Yang, Yanyong, Wang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380384/
https://www.ncbi.nlm.nih.gov/pubmed/35974394
http://dx.doi.org/10.1186/s12943-022-01612-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380384/
https://www.ncbi.nlm.nih.gov/pubmed/35974394
http://dx.doi.org/10.1186/s12943-022-01612-x

Ejemplares similares